Jeffrey Senfield et al. JACEP 2017;3:

Slides:

Advertisements

Similar presentations

Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.

Advertisements

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Effectiveness of CRT and ICD Therapy in.

Noriko Kikuchi et al. JACEP 2016;2:

José L. Morales et al. JACEP 2017;j.jacep

Marwan Badri et al. JACEP 2015;1:

Konstantinos C. Siontis et al. JACEP 2016;2:

Shadi Al Halabi et al. JACEP 2015;1:

David D. Berg et al. JACC 2018;71:

Dileep Raman et al. JACEP 2017;3:

Thomas C. Crawford et al. JACEP 2017;3:

Thomas C. Crawford et al. JACEP 2017;j.jacep

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:

Belinda Gray et al. JCHF 2013;1:

David F. Katz et al. JACEP 2016;j.jacep

Simon W. Rabkin et al. JACEP 2017;j.jacep

Mintu P. Turakhia et al. JACEP 2016;2:

Simon W. Rabkin et al. JACEP 2017;j.jacep

Wesley T. O’Neal et al. JACEP 2016;2:

Muhammad Shahreyar et al. JACEP 2016;j.jacep

Simon W. Rabkin et al. JACEP 2017;3:

Simon W. Rabkin et al. JACEP 2017;3:

Volume 9, Issue 1, Pages (January 2012)

Imran Niazi et al. JACEP 2017;j.jacep

Giuseppe Boriani et al. JACEP 2016;2:

Mahesh Anantha Narayanan et al. JACEP 2017;3:

John A. Bittl et al. JACC 2016;68:

Jonathan M. Behar et al. JACEP 2017;3:

Mintu P. Turakhia et al. JACEP 2016;2:

Prakash Harikrishnan et al. JACEP 2015;1:

Konstantinos C. Siontis et al. JACEP 2016;2:

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;j.jacep

Svend A. Mortensen et al. JCHF 2014;2:

S.M. Afzal Sohaib et al. JACEP 2015;1:

Prabhat Kumar et al. JACEP 2016;j.jacep

Wouter M. van Everdingen et al. JACEP 2015;1:

Emilce Trucco et al. JACEP 2018;j.jacep

Marwan Badri et al. JACEP 2015;1:

Vittorio Calzolari et al. JACEP 2017;3:

Kenshi Hayashi et al. JACEP 2016;2:

Adam B. Greenbaum et al. JACEP 2015;1:

David F. Katz et al. JACEP 2017;3:20-28

Connie W. Tsao et al. JCHF 2016;4:

Simon W. Rabkin et al. JACEP 2017;j.jacep

Peter E. Carson et al. JCHF 2015;3:

Simon W. Rabkin et al. JACEP 2017;3:

Simon W. Rabkin et al. JACEP 2017;3:

Emilce Trucco et al. JACEP 2018;j.jacep

K.R. Julian Chun et al. JACEP 2017;3:

Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Maria Rosa Costanzo et al. JCHF 2016;4:95-105

Jordan B. King et al. JCHF 2016;4:

T2DM patients with HF may benefit from SGLT2 inhibitor therapy

Davide Capodanno et al. JCIN 2009;2:

Connie W. Tsao et al. JCHF 2016;4:

Saadia Sherazi et al. JACEP 2015;1:74-80

Cost-effectiveness plane for all PARTNER-B vs all ADVANCE and all PARTNER vs ADVANCE high risk comparisons with ICERs from five studies; dashed line represents.

Christian Madelaire et al. JCHF 2018;6:

Rick A. Nishimura et al. JACC 2017;70:

Pamela E. Scott et al. JACC 2018;71:

Increase of physical activity over time associated with lower HF risk

Leonard M. Rademakers et al. JACEP 2016;2:

Anneline S.J.M. te Riele et al. JACEP 2015;1:

Orly Vardeny et al. JCHF 2016;4:

Thomas A. Dewland et al. JACEP 2015;1:

Gianluigi Savarese et al. JCHF 2016;4:

Kaplan-Meier plot for the prespecified primary endpoint (CARE-HF (A) and the secondary composite endpoint (all-cause mortality and new onset heart failure.

Daniele Muser et al. JACEP 2017;j.jacep

Presentation transcript:

Jeffrey Senfield et al. JACEP 2017;3:818-826 Time to HF Hospitalization or Death by Randomization With the PR Interval Dichotomized at 180 ms Composite endpoint for time to heart failure hospitalization or death for PR ≤180 ms and PR >180 ms. There was no statistical difference in the interaction p value between the 2 groups (p = 0.33). CRT OFF = cardiac resynchronization therapy control group; CRT ON = group actively on cardiac resynchronization therapy; HF = heart failure; HR = hazard ratio. Jeffrey Senfield et al. JACEP 2017;3:818-826 2017 American College of Cardiology Foundation